The standard of perfection: Thoughts about the laying hen model of ovarian cancer

Cancer Prevention Research

Volumn 2, Issue 2, 2009, Pages 97-99

  Johnson, Karen A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; GESTAGEN; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; VITAMIN D; TUMOR MARKER;

ANTIGEN EXPRESSION; APOPTOSIS; CANCER LOCALIZATION; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CONNECTIVE TISSUE; EGG PRODUCTION; GENETIC VARIABILITY; HEN; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; MORPHOLOGY; NONHUMAN; OVARY ADENOCARCINOMA; OVARY CANCER; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; ADENOCARCINOMA; ANIMAL; CHEMISTRY; CHICKEN; DISEASE MODEL; FEMALE; GENETICS; MUTATION; NOTE; OVARY TUMOR; PATHOLOGY;

ADENOCARCINOMA; ANIMALS; CHICKENS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MUTATION; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 63249096638     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-08-0244     Document Type: Review

References (26)

1. Fredrickson TN. Ovarian tumors of the hen. Environ Health Perspect 1987;73:35-51.
2. International Chicken Polymorphism Map Consortium. A genetic variation map for chicken with 2.8 million single nucleotide polymorphisms. Nature 2004;432:717-722
3. Smith CA, Sinclair AH. Sex determination: insights from the chicken. BioEssays 2004;26:120-132
4. Kindelberger DW, Lee Y, Miron A, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 2007;31:161-169 (Pubitemid 46175016)
5. Yu JY-L, Marquardt RR. Development, cellular growth, and function of the avian oviduct. Biol Reproduct 1973;8:283-298
6. Johnson AL, Johnson PA, Van Tienhoven A. Ovulatory response, and plasma concentrations of luteinizing hormone and progesterone following administration of synthetic mammalian or chicken luteinizing hormone-releasing hormone relative to the first or second ovulation in the sequence of the domestic hen. Biol Reproduct 1984;31:646-655 (Pubitemid 15184930)
7. Jackson E, Anderson K, Ashwell C, et al. CA125 expression in spontaneous ovarian adenocarcinomas from laying hens. Gynecol Oncol 2007;104:192-198 (Pubitemid 46054125)
8. Urick ME, Giles JR, Johnson PA. VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer. Gynecol Oncol 2008;110:418-424
9. Hakim AA, Barry CP, Barnes J, et al. Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras and HER-2/neu. Cancer Prev Res
10. Landen CN, Birrer MJ, Sood AK. Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol 2008;26:995-1005.
11. Kurman RJ, Visvanathan K, Roden R, et al. Early detection and treatment of ovarian cancer; shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol 2008;198:351-356
12. American Poultry Association. The American standard of perfection: a complete description of all recognized varieties of fowls. Davenport (IA): American Poultry Association; 1942.
13. International Chicken Genome Sequencing Consortium. Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution. Nature 2004;432;695-716.
14. Affymetrix. GeneChip® Chicken Genome Array, Data Sheet. Available from: http://www.affymetrix.com/products-services/arrays/specific/chicken.affx.
15. Herschkowitz jl, Simin K, Weigman VJ, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007;8:R76.
16. Sortie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869-10874 (Pubitemid 32878711)
17. Troester MA, Herschkowitz JI, Oh DS, et al. Gene expression patterns associated with p53 status in breast cancer. BMC Cancer 2006;6:276-289
18. Jarboe E, Folkins A, Nucci MR, et al. Serous carcinogenesis in the fallopian tube: a descriptive classification. Int J Gynecol Pathol 2007;27:1-9.
19. Rodriguez GC, Carver D, Anderson K, et al. Evaluation of ovarian cancer preventive agents in the chicken. Gynecol Oncol 2001;80:317.
20. Barnes MN, Berry WD, Straughn MJ, et al. A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis. Gynecol Oncol 2002;87:57-63.
21. Beral V, Doll R, Hermon C, Peto R, Reeves G. Writing Committee for the Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87303 controls. Lancet 2008;371:303-314
22. Rodriguez GC, Nagarsheth NP, Lee KL, et al. Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-beta. J Natl Cancer Inst 2002;94:50-60.
23. Brewer M, Ranger-Moore J, Sattterfield W, et al. Combination of 4-HPR and oral contraceptive in monkey model of chemoprevention of ovarian cancer. Front Biosci 2007;12:2260-2268
24. Bell DD. Historical and current molting practices in the U.S. table egg industry. Poultry Sci 2003;82: 965-970
25. Schildkraut JM, Calingaert B, Marchbanks PA, Moorman PG, Rodriguez GC. Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk. J Natl Cancer Inst 2002;94:32-38 (Pubitemid 34082841)
26. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998;90:1774-1786